GEN Exclusives

More »

GEN News Highlights

More »
Mar 19, 2007

Eden Biodesign and ImmunoBiology Work on Flu Vaccine

  • Eden Biodesign will provide ImmunoBiology with a range of development and manufacturing services for its vaccine program that targets both seasonal and pandemic flu.

    “Working with Eden Biodesign will allow us to rapidly advance the next generation influenza vaccine forward towards a clinical trial application and is consistent with our aggressive timelines for bringing our viral lead product to the clinic,” says Graham Clarke, CEO of ImmunoBiology. 

    Eden Biodesign is the operator of the National Biomanufacturing Center (NBC) facility.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Using Pet Dogs with Cancer in Preclinical Trials

Do you agree that pet dogs with cancer should be used in early cancer drug trials?

More »